Share article:
Share article:

France and UK remain confident in AstraZeneca vaccine

Credit: Belga

The United Kingdom will continue to use the AstraZeneca vaccine even after a study showed the vaccine has limited efficacy against the South African variant, British vaccines minister Nadhim Zahawi told The Telegraph newspaper on Monday.

French Health Minister Olivier Véran also says he has confidence in the vaccine.

The British government has “confidence” in its current vaccination plan and in the “protection it will provide us all against this terrible disease,” according to Zahawi. “We need to be aware that a vaccine may still be effective against severe forms of the disease, hospitalisation and death, even if it is less effective in preventing infection,” he added.

French Health Minister Olivier Véran said on Monday during his own vaccination with the AstraZeneca vaccine that it is totally reliable and offers sufficient protection against almost all variants of the virus.

Related News

 

On Sunday, the Financial Times reported that the vaccine from the Anglo-Swedish company and Oxford University offered only limited protection against mild and moderate forms of the disease caused by the coronavirus.

AstraZeneca has already stated that the study in question was carried out on 2,000 young, healthy people and that the company was convinced that the vaccine will protect people against severe forms because it produces neutralising antibodies similar to other vaccines against the virus.

According to British Deputy Health Minister Edward Argar, 147 South African variant infections have been identified in the UK.

The Brussels Times

Latest news

No crowds, limited events: these measures take effect today
Most of Belgium's latest measures already took effect on Saturday, but some changes – concerning public events, sports competitions and schools – ...
Brussels and Liège residents invited to sleep rough to raise awareness for homeless
As temperatures dip below freezing, sleeping on the streets becomes potentially life-threatening, even without factoring in the myriad other hazards ...
Belgium in Brief: Delta, Gamma… Omicron?
Since June, the World Health Organisation (WHO) is no longer calling newly-discovered coronavirus "variants of concern" after the country where they ...
Omicron variant poses ‘very high’ global risk, warns WHO
The Omicron coronavirus variant poses a "very high" global risk for which countries must be well-prepared, said the World Health Organisation (WHO) ...
De Croo: ‘The one certainty that we can rely on is the impact of our personal behaviour’
On Monday morning, Prime Minister Alexander De Croo spoke on La Première radio station about the recently-announced coronavirus measures and, in ...
Booster vaccines already available for all Brussels residents
All residents of the Brussels-Capital Region from 18 years old can make an appointment for a third/booster dose against the coronavirus from this ...
Covid-19 decisions made ‘too hastily’, socialist leader argues
The government is missing a "general lack of method" when it comes to how coronavirus fighting measures are decided on, according to the leader of ...
Aggression against railway staff more than doubled since 2020
In the first three quarters of 2021, the number of reports of aggression against national railway company SNCB's staff has more than doubled compared ...
Intervention hotline 1722 activated following bad weather warnings
Following bad weather warnings from Belgium's Royal Meteorological Institute of Belgium (RMI), the Federal Public Service (FPS) Home Affairs has ...
Several rush hour train services to be scrapped from Monday
Up to ten peak time trains to and from Brussels will be temporarily cancelled starting from Monday, Belgian railway company SNCB announced this ...
Thousands march in Brussels to raise awareness of violence against women
More than 3,000 people took to the streets of Brussels on Sunday afternoon for a national march to raise awareness of violence against women in ...
Efficacy of vaccines against new variant known in a few weeks, virologist says
The efficacy of the current coronavirus vaccines against the new Omicron variant will be clear in one to two weeks, Belgian virologist Marc Van Ranst ...